EMCDDA Home
  • EN

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (viii) All inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates27.055.969.767.060.059.249.331.2115081075
Cocaine2.34.36.29.110.110.06.51.41080140
Stimulants19.319.511.99.99.76.97.44.13271210
Hypnotics and sedatives3.52.63.65.711.615.828.152.21009261
Hallucinogens0.30.20.10.00.10.00.00.0367
Volatile substances5.01.40.50.30.00.90.50.331410
Cannabis 39.214.16.86.96.54.94.62.43000301
Other substances 3.32.01.21.12.02.23.78.5417259
Total2910936846541908834449217295206352263

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU,HU, AT, RO, SK, FI, SE, HR, TR. 

 Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010